Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen

The antisense oligonucleotide nusinersen has been shown to improve trunk and limb motor function in patients with spinal muscular atrophy (SMA). Bulbar dysfunction, which is regularly present in SMA, is not captured by standard motor scores, and validated measurement instruments to assess it have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Brakemeier, Svenja, Stolte, Benjamin, Thimm, Andreas, Kizina, Kathrin, Totzeck, Andreas, Munoz-Rosales, Juan, Kleinschnitz, Christoph, Hagenacker, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470195/
https://www.ncbi.nlm.nih.gov/pubmed/34573264
http://dx.doi.org/10.3390/brainsci11091244

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470195/
https://www.ncbi.nlm.nih.gov/pubmed/34573264
http://dx.doi.org/10.3390/brainsci11091244

Ejemplares similares